Headquarters
China / USA
Every company in the roster headquartered in China / USA.
Research
Compare company financial metrics
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
Headquarters
Every company in the roster headquartered in China / USA.
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
5 of 5 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
NovaBridge BiosciencesNBP · Nasdaq | 2 assets: 2 Ph 2 | olamkiceptPhase 2 · Ulcerative ColitisPartial signal | Dec 2026givastomig · Phase 1 |
Regor PharmaceuticalsPrivate | 2 assets: 2 Ph 2 | regor GLP-1Phase 2 · ObesityPartial signal | 30 Dec 2026RGT-419B · Phase 1 |
Corxel PharmaceuticalsPrivate | 1 asset: 1 Ph 3 | CX11Phase 3 · ObesityReliable signal | Mar 2027CX11 · Phase 1 |
Insilico Medicine3696 · HKEX | 1 asset: 1 Ph 2 | garutadustatPhase 2 · Ulcerative Colitis | 15 Aug 2027garutadustat · Phase 2 |
TheracosPrivate | 1 asset: 1 approved | Approved assets only | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).